Impact
17+
Therapeutic areas
+15%
Diverse audiences enrolled
+25%
Accelerated time to recruitment closeout
Challenge
Johns Hopkins University and the Department of Defense (DoD) faced a major challenge during Covid-19: launching a clinical trial to evaluate a treatment and enroll a diverse population—all while the pandemic surged globally. But after five months, 25+ trial sites had enrolled just 2% of their 1,000+ target, with minority groups under-represented. They needed a new approach, fast—and came to us to turn things around.
Approach
We activated CTRx Pathways, a new platform for trial recruitment. Using a disease-based media model, we delivered personalized messages through the most relevant channels. We also built credibility and awareness through community influencers, geofenced testing centers, search, social, outdoor media, and a strong PR campaign in target cities.
Candidates were driven to the CTRx Web Platform to learn, pre-qualify, and start enrollment. From there, our HIPAA-compliant CTRx Enrollment Software provided full visibility from candidacy to consent, enabling real-time optimization at every stage.
The trial generated 500M+ earned and paid media impressions, 500K+ website and call center visits, and over 1,000 pre-qualified candidates routed to clinical trial sites. Results were published in The New England Journal of Medicine, leaving a lasting mark on science and public health.
Learn more about our CTRx model at our website.
